首页 | 本学科首页   官方微博 | 高级检索  
     

多西他赛与吉西他滨分别顺泊治疗晚期非小细胞肺癌的临床研究
作者单位:The Fourth District of Chemotherapy, Department of Medical Oncology, Central Hospital of Guangdong Provincial Agricultral Reclamation, Zhanjiang 524002, China
摘    要:


关 键 词:吉西他滨  多西他赛  顺铂治疗  晚期非小细胞肺癌  临床研究  
收稿时间:2007-09-28

Clinical observation of docetaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer
Yongguang Cai,Ming Li,Xin Xie. Clinical observation of docetaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer[J]. The Chinese-German Journal of Clinical Oncology, 2011, 10(8): 472-475. DOI: 10.1007/s10330-011-0810-y
Authors:Yongguang Cai  Ming Li  Xin Xie
Affiliation:(The Fourth District of Chemotherapy, Department of Medical Oncology, Central Hospital of Guangdong Provincial Agricultral Reclamation, Zhanjiang 524002, China) ;
Abstract:
Objective:The aim of this study was to evaluate the clinical efficacy and side effects of docetaxel/cisplatin regiment and gemcitabine/cisplatin regiment in the patients with advanced non-small-cell lung cancer (NSCLC).Methods:Seventy-six patients with advanced NSCLC who were chemotherapy-naive were enrolled in two groups.In docetaxel group (DP group) the patients received docetaxel 75 mg/m 2 and cisplatin 60mg/m 2 on day 1.In gemcitabine group (GP group) the patients received gemcitabine 1000mg/m 2 on day ...
Keywords:docetaxel/cisplatin  gemcitabine/cisplatin  advanced non-small-cell lung cancer (NSCLC)  
本文献已被 CNKI 万方数据 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号